WASHINGTON -- Rheumatoid arthritis (RA) patients who achieved sustained remission had better long-term outcomes than those ...

There are multiple chapters near you. Select your preferred chapter.

Upadacitinib 15 mg plus a 26-week GC taper outperformed placebo in combination with a 52-week GC taper for the treatment of ...

Many patients with rheumatic diseases refrain from telling their doctors about all physical and emotional symptoms they’re ...

When the session moderator asked whether the findings meant cardiovascular risk was no longer a worry with JAK inhibitors ...